ST
STE
STERIS plc
$207.56
+0.16%
$20.3B
No data for this timeframe.
Vol
Market Cap$20.3B
Cap SizeLarge Cap
Analyst ConsensusBuy (67%)
Insider Activity0B / 3S
Insider Net $-$1.3M
SEC Reports8
Congressional2 trades
Exchange NYSE·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. L2·CIK 0001757898·Prev Close $207.22
Recent Activity
Jun 11, 2026
SEC
STERIS plc filed a DEFA14A (definitive additional proxy soliciting materials) providing notice of its 2026 Annual Genera
DEFA14A — Impact 2/10
Jun 8, 2026
SEC
CEO Daniel Carestio and Director Richard Breeden sold a combined $966K in open-market STE shares over a 5-day window (Ma
CLUSTER — Impact 3/10
Jun 5, 2026
SEC
Daniel A. Carestio, an officer and director of STERIS plc, filed a Form 144 notice of intent to sell 1,374 ordinary shar
144 — Impact 2/10
Jun 5, 2026
Insider
Carestio Daniel A sold 1,374 shares
President and CEO @ $212.00 ($291.3K)
Jun 4, 2026
Insider
Burton Karen L surrendered for taxes 90 shares
Sr. Vice Pres., CFO @ $212.24 ($19.1K)
Jun 4, 2026
Insider
Fraser Mary Clare surrendered for taxes 600 shares
SVP & Chief HRO @ $212.24 ($127.3K)
May 18, 2026
dark_pool
Dark Pool: STE — 1.1M shares, 31,664 trades
Week starting 2026-05-18. Total ATS volume: 1,079,098 shares across 31,664 trades.
Apr 30, 2026
Congress
April McClain Delaney buy
$1,001 - $15,000 — House
Price Targets
$256.86
+23.8% upside
Strong Buy
Current $207.56
Low $225.00
Median $269.00
High $280.00
7 analysts
$225.00
$280.00
Analyst Ratings
3Strong Buy
7Buy
5Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 13, 2026 | Keybanc | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $2.50 | $2.44 — $2.58 | 7% YoY | 7 |
| Next Q | $2.70 | $2.66 — $2.76 | 9% YoY | 7 |
| Current FY | $11.16 ▲ +0.7% | $11.08 — $11.21 | 10% YoY | 8 |
| Next FY | $12.11 | $11.61 — $12.34 | 8% YoY | 8 |
Latest Reports
NEUTRAL
DEFA14A
2/10
STERIS plc filed a DEFA14A (definitive additional proxy soliciting materials) providing notice of its 2026 Annual Genera
Jun 11, 2026
NEUTRAL
CLUSTER
3/10
CEO Daniel Carestio and Director Richard Breeden sold a combined $966K in open-market STE shares over a 5-day window (Ma
Jun 8, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 5, 2026 | Carestio Daniel | SELL | $291.3K |
| Jun 4, 2026 | Burton Karen | F | $19.1K |
| Jun 4, 2026 | Fraser Mary | F | $127.3K |
| Jun 4, 2026 | Carestio Daniel | SELL | $655.5K |
| Jun 4, 2026 | Carestio Daniel | F | $400.9K |
Congressional Trades
1 members: 2 buys, 0 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| April McClain | D | BUY | $1,001 - $15,000 |
| April McClain | D | BUY | $1,001 - $15,000 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
11 unique insiders with 50 transactions. Net insider value: -$1.3M ($0.00 bought, $1.3M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Carestio Daniel A | President and CEO | SELL | 1,374 | $212.00 | $291.3K |
| Jun 4, 2026 | Burton Karen L | Sr. Vice Pres., CFO | TAX W/H | 90 | $212.24 | $19.1K |
| Jun 4, 2026 | Fraser Mary Clare | SVP & Chief HRO | TAX W/H | 600 | $212.24 | $127.3K |
| Jun 4, 2026 | Carestio Daniel A | President and CEO | SELL | 3,054 | $214.64 | $655.5K |
| Jun 4, 2026 | Carestio Daniel A | President and CEO | TAX W/H | 1,889 | $212.24 | $400.9K |
| Jun 4, 2026 | Kohler Kenneth E | SVP & GM, AST | TAX W/H | 150 | $212.24 | $31.8K |
| Jun 4, 2026 | Madsen Julia | Sr. VP and GM, Life Sciences | TAX W/H | 195 | $212.24 | $41.4K |
| Jun 4, 2026 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | TAX W/H | 401 | $212.24 | $85.1K |
| Jun 3, 2026 | Burton Karen L | Sr. Vice Pres., CFO | TAX W/H | 190 | $210.19 | $39.9K |
| Jun 3, 2026 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | TAX W/H | 365 | $210.19 | $76.7K |
| Jun 3, 2026 | Madsen Julia | Sr. VP and GM, Life Sciences | TAX W/H | 239 | $210.19 | $50.2K |
| Jun 3, 2026 | Tamaro Renato | V.P. & Corporate Treasurer | TAX W/H | 64 | $210.19 | $13.5K |
| Jun 3, 2026 | Fraser Mary Clare | SVP & Chief HRO | TAX W/H | 311 | $210.19 | $65.4K |
| Jun 3, 2026 | Kohler Kenneth E | SVP & GM, AST | TAX W/H | 184 | $210.19 | $38.7K |
| Jun 3, 2026 | Carestio Daniel A | President and CEO | TAX W/H | 2,619 | $210.19 | $550.5K |
| Jun 2, 2026 | Carestio Daniel A | President and CEO | AWARD | 23,736 | — | — |
| Jun 2, 2026 | Carestio Daniel A | President and CEO | TAX W/H | 995 | $209.76 | $208.7K |
| Jun 2, 2026 | Carestio Daniel A | President and CEO | AWARD | 82,740 | — | — |
| Jun 2, 2026 | Burton Karen L | Sr. Vice Pres., CFO | AWARD | 5,325 | — | — |
| Jun 2, 2026 | Burton Karen L | Sr. Vice Pres., CFO | EXERCISE | 66 | $209.76 | $13.8K |
| Jun 2, 2026 | Burton Karen L | Sr. Vice Pres., CFO | AWARD | 18,564 | — | — |
| Jun 2, 2026 | Boulud Pierre | Director | AWARD | 367 | — | — |
| Jun 2, 2026 | Breeden Richard C | Director | SELL | 1,481 | $209.51 | $310.3K |
| Jun 2, 2026 | Breeden Richard C | Director | EXERCISE | 3,781 | $71.40 | $270.0K |
| Jun 2, 2026 | Kohler Kenneth E | SVP & GM, AST | AWARD | 2,199 | — | — |
| Jun 2, 2026 | Kohler Kenneth E | SVP & GM, AST | TAX W/H | 66 | $209.76 | $13.8K |
| Jun 2, 2026 | Fraser Mary Clare | SVP & Chief HRO | AWARD | 3,009 | — | — |
| Jun 2, 2026 | Fraser Mary Clare | SVP & Chief HRO | TAX W/H | 591 | $209.76 | $124.0K |
| Jun 2, 2026 | Fraser Mary Clare | SVP & Chief HRO | AWARD | 10,492 | — | — |
| Jun 2, 2026 | Kohler Kenneth E | SVP & GM, AST | AWARD | 7,668 | — | — |
| Jun 2, 2026 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | AWARD | 4,359 | — | — |
| Jun 2, 2026 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | TAX W/H | 247 | $209.76 | $51.8K |
| Jun 2, 2026 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | AWARD | 15,200 | — | — |
| Jun 2, 2026 | McGowan Lindsey | VP, Chf. Comp. & Quality Offc. | TAX W/H | 329 | $209.76 | $69.0K |
| Jun 2, 2026 | Tamaro Renato | V.P. & Corporate Treasurer | AWARD | 750 | — | — |
| Jun 2, 2026 | Tamaro Renato | V.P. & Corporate Treasurer | TAX W/H | 41 | $209.76 | $8.6K |
| Jun 2, 2026 | Tamaro Renato | V.P. & Corporate Treasurer | AWARD | 2,620 | — | — |
| Jun 2, 2026 | McGowan Lindsey | VP, Chf. Comp. & Quality Offc. | AWARD | 1,155 | — | — |
| Jun 2, 2026 | McGowan Lindsey | VP, Chf. Comp. & Quality Offc. | AWARD | 4,036 | — | — |
| Jun 2, 2026 | Majors Cary L | SVP and President, Healthcare | AWARD | 4,746 | — | — |
| Jun 2, 2026 | Majors Cary L | SVP and President, Healthcare | TAX W/H | 67 | $209.76 | $14.1K |
| Jun 2, 2026 | Madsen Julia | Sr. VP and GM, Life Sciences | AWARD | 2,316 | — | — |
| Jun 2, 2026 | Majors Cary L | SVP and President, Healthcare | AWARD | 16,548 | — | — |
| Jun 2, 2026 | Madsen Julia | Sr. VP and GM, Life Sciences | TAX W/H | 127 | $209.76 | $26.6K |
| Jun 2, 2026 | Madsen Julia | Sr. VP and GM, Life Sciences | AWARD | 8,080 | — | — |
| Jun 1, 2026 | Burton Karen L | Sr. Vice Pres., CFO | TAX W/H | 99 | — | — |
| Jun 1, 2026 | Kohler Kenneth E | SVP & GM, AST | TAX W/H | 109 | — | — |
| Jun 1, 2026 | Majors Cary L | SVP and President, Healthcare | TAX W/H | 768 | — | — |
| Jun 1, 2026 | Fraser Mary Clare | SVP & Chief HRO | TAX W/H | 673 | — | — |
| Jun 1, 2026 | Carestio Daniel A | President and CEO | TAX W/H | 1,254 | — | — |
8 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 6 neutral. Avg impact: 3.4/10.
NEUTRAL
DEFA14A
2/10
STERIS plc filed a DEFA14A (definitive additional proxy soliciting materials) providing notice of it
Jun 11, 2026
NEUTRAL
CLUSTER
3/10
CEO Daniel Carestio and Director Richard Breeden sold a combined $966K in open-market STE shares ove
Jun 8, 2026
NEUTRAL
144
2/10
Daniel A. Carestio, an officer and director of STERIS plc, filed a Form 144 notice of intent to sell
Jun 5, 2026
NEUTRAL
144
2/10
Daniel A. Carestio, an officer and director of STERIS plc, filed a Form 144 notice to sell 3,054 ord
Jun 4, 2026
MIXED
PRESS-RELEASE
6/10
STERIS reported fiscal Q4 2026 adjusted EPS of $2.83, slightly above the $2.74 prior year but below
May 11, 2026
BEARISH
8-K
7/10
STERIS reported fiscal Q4 2026 GAAP diluted EPS of $2.24, significantly below the $2.85 consensus es
May 11, 2026
NEUTRAL
8-K
2/10
STERIS filed an 8-K reporting the retirement of director Richard C. Breeden (not standing for reelec
May 7, 2026
NEUTRAL
PRESS-RELEASE
3/10
STERIS plc announced it will host a conference call to discuss its Q4 and full-year fiscal 2026 resu
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (67% buy). Based on 15 analysts: 3 strong buy, 7 buy, 5 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$256.86 mean target
+23.8% upside
Strong Buy (1.88)
$225.00 Low
$280.00 High
| Metric | Value |
|---|---|
| Current Price | $207.56 |
| Target Low | $225.00 |
| Target Mean | $256.86 |
| Target Median | $269.00 |
| Target High | $280.00 |
| # Analysts | 7 |
| Recommendation | Strong Buy (1.88) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$2.50 | $2.44 | $2.58 | 6.9% | +0.4% | 2↑ 2↓ | $1.5B | 7.6% | 7 |
| Next Q 2026-09-30 |
$2.70 | $2.66 | $2.76 | 9.2% | +0.1% | 3↑ 2↓ | $1.6B | 6.8% | 7 |
| Current FY 2027-03-31 |
$11.16 | $11.08 | $11.21 | 9.8% | +0.7% | 3↑ 3↓ | $6.4B | 7.3% | 8 |
| Next FY 2028-03-31 |
$12.11 | $11.61 | $12.34 | 8.5% | -0.3% | 1↑ 3↓ | $6.8B | 6.3% | 8 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $2.501 | |
| 7d ago | $2.501 | |
| 30d ago | $2.492 | +0.009 |
| 60d ago | $2.492 | +0.009 |
| 90d ago | $2.517 | -0.015 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 13, 2026 | Keybanc | MAINTAIN | Overweight | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 7 | 5 | 0 | 0 | 67% | |
| May 1, 2026 | 3 | 7 | 5 | 0 | 0 | 67% | |
| Apr 1, 2026 | 3 | 7 | 5 | 0 | 0 | 67% | |
| Mar 1, 2026 | 3 | 6 | 5 | 0 | 0 | 64% | |
| Feb 1, 2026 | 3 | 6 | 5 | 0 | 0 | 64% | |
| Jan 1, 2026 | 3 | 6 | 4 | 0 | 0 | 69% |
Strong BuyBuyHoldSellStrong Sell
1 members of Congress traded this stock: 2 buys, 0 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | April McClain Delaney | D | HOUSE | BUY | $1,001 - $15,000 | Steris PLC | May 7, 2026 (8d) |
| Feb 6, 2026 | April McClain Delaney | D | HOUSE | BUY | $1,001 - $15,000 | Steris PLC | Mar 11, 2026 (34d) |
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 18, 2026
dark_pool
Dark Pool: STE — 1.1M shares, 31,664 trades
Week starting 2026-05-18. Total ATS volume: 1,079,098 shares across 31,664 trades.
May 12, 2026
short_volume
Short Volume: STE — 63.7% short (0.6M / 0.9M)
Short: 553,277 | Exempt: 8 | TRF Vol: 868,259 | Short Ratio: 63.7% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_interest
FTD: STE — 13,354 shares ($2.7M) failed to deliver
Settlement: 20260512, Price: $201.85, FTD Value: $2,695,504.9, STERIS PLC ORD SHS(IRL)
May 11, 2026
earnings
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
<p>DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its f
May 11, 2026
earnings_calendar
STE Q4 2026 Earnings After Market Close — 2026-05-11
May 11, 2026
dark_pool
Dark Pool: STE — 1.9M shares, 45,626 trades
Week starting 2026-05-11. Total ATS volume: 1,944,059 shares across 45,626 trades.
May 7, 2026
announcement
STERIS Appoints Pierre Boulud to Board of Directors
<p>DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026
May 5, 2026
dividend
STERIS Announces Dividend of $0.63 per share
<p>DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distr
May 4, 2026
dark_pool
Dark Pool: STE — 0.9M shares, 33,475 trades
Week starting 2026-05-04. Total ATS volume: 884,945 shares across 33,475 trades.
Apr 27, 2026
dark_pool
Dark Pool: STE — 1.0M shares, 33,067 trades
Week starting 2026-04-27. Total ATS volume: 974,648 shares across 33,067 trades.
Apr 21, 2026
earnings
STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
<p>DUBLIN, IRELAND, April 21, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a confer
Apr 20, 2026
dark_pool
Dark Pool: STE — 1.0M shares, 27,569 trades
Week starting 2026-04-20. Total ATS volume: 973,820 shares across 27,569 trades.
Apr 13, 2026
dark_pool
Dark Pool: STE — 1.1M shares, 36,321 trades
Week starting 2026-04-13. Total ATS volume: 1,079,777 shares across 36,321 trades.
Apr 6, 2026
dark_pool
Dark Pool: STE — 0.7M shares, 22,995 trades
Week starting 2026-04-06. Total ATS volume: 674,269 shares across 22,995 trades.
Mar 30, 2026
dark_pool
Dark Pool: STE — 0.9M shares, 28,020 trades
Week starting 2026-03-30. Total ATS volume: 900,676 shares across 28,020 trades.